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ABSTRACT 
Terson’s syndrome has had multiple definitions. The original definition is unlikely to have included Terson’s 
original case. An updated definition based on mechanism is proposed and related to the original case 
described by Terson. 
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INTRODUCTION  
Paunoff firstly defined Terson’s syndrome in 1962 [1] as 
vitreous hemorrhage in association with subarachnoid 
hemorrhage (SAH) and named it for a 1900 article by Terson 
[2]. However, Terson’s case may not have fit this definition. The 
definition has been modified with time, using a combination of 
signs to identify it. The changes in the definition and the 
reasons for these changes are discussed and a definition based 
on mechanism proposed. 
 
HYPOTHESIS  
Syndromes are defined as a collection of signs and/or 
symptoms identifying a particular disease process. A disease 
may also be defined by it’s cause. It is suggested that Terson’s 
syndrome be defined in this manner, as intraocular 
hemorrhage caused by an abrupt increase in intracranial 
pressure (ICP). 
 
DISCUSSION 
When Paunoff defined Terson’s syndrome, it is unlikely the case 
originally describes by Terson would have fit the definition. 
Although there is no doubt Terson’s case had vitreous 
hemorrhage, it is not at all evident it had SAH.  
Both Terson and Paunoff discuss the importance of vitreous 
hemorrhage in this condition, noting the possibility that such 
hemorrhage might arise directly from blood tracking directly 
from the brain through the optic nerve sheaths and into the 
vitreous. Even Terson thought this unlikely since pathology 
specimens already existed showing intracranial and vitreous 
hemorrhage with no hemorrhage in the optic nerve sheaths. He 
also thought significant optic nerve sheath hemorrhage in his 
case to be unlikely since his patient achieved good recovery of 
vision. That the vitreous hemorrhage arose instead from the 
retinal vasculature was also considered (and preferred) by both 
Terson and Paunoff. It is now generally agreed that both the 
subarachnoid and subdural spaces of the optic nerve “end 
blindly. They do not communicate with any of the intraocular 
chambers” [3]. Thus, although extension of intracranial 
hemorrhage by this route is not possible, it still persists in the 
modern literature. With the realization that the vitreous 
hemorrhage comes from the retinal vasculature, the 
differentiation of cases with hemorrhage in the retinal layers 
from those where such hemorrhage broke through the internal 
limiting membrane became unimportant and the definition of 
Terson’s syndrome was modified to include any intraocular 
hemorrhage.  
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The importance of SAH has also undergone revision. As noted 
above, the original definition included SAH but it is unlikely 
Terson’s 1900 case had SAH since this is usually accompanied 
by severe headache with localizing signs appearing later while, 
Terson’s case awoke with hemiplegia and was more likely a 
cerebral vascular accident, either hemorrhagic or non-
hemorrhagic. Terson thought it was hemorrhagic but admitted 
he could not be certain. The subarachnoid location, rather than 
subdural, is usually from an arterial source and might produce a 
more abrupt ICP elevation than a subdural bleed which is often 
of venous origin. However intraocular hemorrhage has been 
noted with subdural hemorrhage (SDH) and the definition 
expanded to include any intracranial hemorrhage. 
Both of these changes are well demonstrated by the definitions 
of Terson’s syndrome in the American Academy of 
Ophthalmology’s Basic and Clinical Science course which in the 
1984-85 edition says “Terson syndrome is vitreous hemorrhage 
in association with subarachnoid hemorrhage” while the 2012 
definition states “Terson syndrome is recognized as vitreous 
and sub-ILM or subhyaloid hemorrhage caused by an abrupt 
intracranial hemorrhage”. 
Intraocular hemorrhage also occurs with other intracranial 
events other than hemorrhage, such as in meningitis and crush 
injuries.  
Defining a condition by mechanism rather than by a collection 
of signs allows a more scientific analysis. Thus it is proposed 
Terrson’s syndrome be defined as hemorrhage from the retinal 
vasculature caused by an increase in intracranial pressure , just 
as papilledema is defined as optic nerve head swelling from 
imcreased ICP. Smith and Kearns [4] have produced such retinal 
hemorrhage in a non-human primate and Firsching [5] has 
shown that in the great majority of cases in humans, pressure 
in the intraocular portion of the central retinal vein directly 
reflects ICP. Thus, as suggested by Muller [6] and others, 
increased ICP may cause the intraocular hemorrhage seen in 
Terson’s syndrome. The pattern and degree of hemorrhage 
may reflect the time course of ICP elevation. 
 
CONCLUSION 
Defining Terson’s syndrome by mechanism will allow conditions 
such as intracranial hemorrhages of any source (subarachnoid, 
subdural, epidural, intraventricular) as well as non-hemorrhagic 
conditions such as infection or cerebral edema from multiple 
causes to be compared. It will also insure that Terson’s original 
case is included. 
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